https://orcid.org/0000-0002-2058-9225
References
- Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21. doi:https://doi.org/10.1016/S2213-2600(20)30116-8.
- Agrawal R, Testi I, Lee CS, et al. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic. Br J Ophthalmol. 2020. doi:https://doi.org/10.1136/bjophthalmol-2020-316776.
- Li Y, Xia L. Coronavirus disease 2019 (COVID-19): role of chest CT scan in diagnosis and management. AJR Am J Roentgenol. 2020;214(6):1280–1286. doi:https://doi.org/10.2214/AJR.20.22954.
- Li F, Cai J, Dong N. First cases of COVID-19 in heart transplantation from China. J Heart Lung Transplant. 2020;39(5):496–497. doi:https://doi.org/10.1016/j.healun.2020.03.006.
- Liu B, Wang Y, Zhao Y, et al. Successful treatment of severe COVID-19 pneumonia in a liver transplant recipient. Am J Ttransplant. 2020;20(7):1891–1895. doi:https://doi.org/10.1111/ajt.15901.
- Zhu L, Xu X, Ma K, et al. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant. 2020;20(7):1859–1863. doi:https://doi.org/10.1111/ajt.15869.
- D’Antiga L. Coronaviruses and immunosuppressed patients: the facts during the third epidemic. Liver Transpl. 2020;26(6):832–834. doi:https://doi.org/10.1002/lt.25756.
- Norsa L, Indriolo A, Sansotta N, et al. uneventful course in patients with inflammatory bowel disease during the severe acute respiratory syndrome coronavirus 2 outbreak in Northern Italy. Gastroenterology. 2020;159(1):371–372. doi:https://doi.org/10.1053/j.gastro.2020.03.062.
- Mao R, Liang J, Shen J, et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020;5(5):425–427. doi:https://doi.org/10.1016/S2468-1253(20)30076-5.
- Shahidi-Dadras M, Abdollahimajd F, Ohadi L. et al. COVID-19 in pemphigus vulgaris patients with previous rituximab therapy: a tele-medicine experience. J Dermatolog Treat. 2020;9:1–2. doi:https://doi.org/10.1080/09546634.2020.1789041.
- Park J-E, Jung S, Kim A, et al. MERS transmission and risk factors: a systematic review. BMC Public Health. 2018;18(1):574. doi:https://doi.org/10.1186/s12889-018-5484-8.
- Agarwal AK, Sudharshan S, Mahendradas P, et al. Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY). Br J Ophthalmol. 2020. doi:https://doi.org/10.1136/bjophthalmol-2020-317417.